When Ricky Ramon was 7, he went for a routine checkup. The pediatrician, who lingered over his heartbeat, sent him for a chest X-ray, which revealed a benign tumor in the top-left chamber of his heart. For Ramon, it was the beginning of a long series of medical appointments, procedures and surgeries that would span […]
SMRT Sequencing Offers Significant Improvements for Reference Genomes at Much Lower Cost MENLO PARK, Calif. — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome, with implications for other complex crop and livestock genomes. This new PacBio® genome assembly, produced by scientists at Cold Spring […]
Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment plans for the most common form of lung cancer CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing (NGS)-based test that simultaneously screens tumor samples for biomarkers associated with […]
AMSBIO has introduced a range of purified cancer exosome samples to help researchers study the role of exosomes in cancer development and metastasis. By targeted filtration of patient serum using a specific binding method removes protein contaminant to isolate exosome at 95% high purity. Using this proprietary filtration method, the purified tumor exosome does not […]
Etaluma and DRVision Ink Partnership on Combining Lumascope (LS Microscope) Live Cell Imaging with Aivia Image Visualization and Analysis (Carlsbad, CA) Today Etaluma and DRVision announced a strategic partnership that combines the power of imaging by Etaluma’s next generation inverted LS microscopes (Lumascopes) and DRVision’s innovative image visualization, analysis and data exploration technology called Aivia. […]
Budapest, Hungary – University of Debrecen (UD), Hungary and BGI Group signed a Memorandum of Understanding, Tuesday 20th June, regarding cooperation on the establishment of a local NGS sequencing hub for local population cohort studies and diagnostic testing, and wider collaboration in the research and development of genetic and genomic sciences. The MOU was signed […]
San Diego-based cell culture products supplier announces new, larger headquarters as sales of its Australian origin, fully traceable and characterized fetal bovine serum continues to climb SAN DIEGO – Nucleus Biologics, a premium cell culture products supplier to the biotech and pharmaceutical industries, is announcing it has recently moved to a new 10,511 square foot office […]
LONDON, ON – 3M announced today that Health Canada has approved and published the next-generation 3M Molecular Detection System assay for Listeria detection. Based on isothermal DNA amplification and bioluminescence detection – the same combination of advanced technologies used in all 3M Molecular Detection Assays – these assays use new chemistry to deliver accurate results with shorter […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the launch of ddPCR™ Genome Edit Detection Assays, the first tests to characterize edits generated by CRISPR-Cas9 or other genome editing tools using Bio-Rad’s Droplet Digital PCR (ddPCR) technology. Users can specify their sequences and order assays through Bio-Rad’s Digital Assay Site. Successful genome editing is […]
Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing 4P Health Research […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
